Xu-Xian Chen
Overview
Explore the profile of Xu-Xian Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jin Y, Chen D, Wang F, Yang C, Chen X, You J, et al.
Mol Cancer
. 2020 Oct;
19(1):154.
PMID: 33126883
A more common and noninvasive predicting biomarker for programmed cell death 1 (PD-1) antibody remains to be explored. We assessed 46 patients with advanced gastric cancer who received PD-1 antibody...
2.
He W, Jiang C, Yin C, Guo G, Rong R, Qiu H, et al.
Asian Pac J Cancer Prev
. 2014 Sep;
15(17):7327-31.
PMID: 25227837
Background: We had previously showed that the neutrophil lymphocyte ratio (NLR), γ-glutamyl transpeptidase (GGT) and carcinoembryonic antigen (CEA) are prognostic factors for metastatic colorectal cancer (mCRC) patients. In this study...
3.
Jiang C, Liao F, Rong Y, Yang Q, Yin C, He W, et al.
Asian Pac J Cancer Prev
. 2014 Jul;
15(13):5493-8.
PMID: 25041024
Objective: To compare the efficacy of taxane-based regimens in the first line setting retrospectively in Chinese patients with recurrent and/or metastatic esophageal cancer. Methods: We analyzed 102 recurrent and/or metastatic...
4.
Wang F, Guo G, Qiu H, He W, Zhou F, Chen X, et al.
Cancer Biol Med
. 2013 May;
9(1):38-43.
PMID: 23691453
Objective: The standard therapy after failure of the initial non-first line epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) treatment in advanced non-small cell lung cancer (NSCLC) has not yet...
5.
Autophagy-related proteins Beclin-1 and LC3 predict cetuximab efficacy in advanced colorectal cancer
Guo G, Jiang W, Zhang B, Cai Y, Xu R, Chen X, et al.
World J Gastroenterol
. 2011 Dec;
17(43):4779-86.
PMID: 22147978
Aim: To investigate the utility of Beclin-1 and LC3, two autophagy-related proteins, in predicting the cetuximab efficacy in advanced colorectal cancer (ACRC). Methods: The data of 85 patients with ACRC...
6.
Xia L, Qiu H, Chen X, Hu P, Guo G, Wang F, et al.
Med Oncol
. 2010 Oct;
28 Suppl 1:S570-6.
PMID: 20967514
Cetuximab combined with chemotherapy has been used to treat Non-small cell lung cancer (NSCLC) in recent years, however, the data from China was rare. This study was to summarize our...
7.
Guo G, Xia L, Zhang B, Jiang W, Liu M, Hu P, et al.
Ai Zheng
. 2009 Dec;
28(12):1317-23.
PMID: 19958628
Background And Objective: Studies showed that cetuximab combined with chemotherapy was effective on advanced colorectal cancer (ACRC) in recent years, however, few reports based on large case cohort are available...
8.
Xia L, Zhang B, Liu M, Hu P, Chen X, Guo G, et al.
Ai Zheng
. 2009 Sep;
28(9):977-82.
PMID: 19728918
Background And Objective: Cetuximab combined with radiotherapy or chemotherapy has been used to treat head and neck cancer in recent years, but few reports are available in China now. This...
9.
Zhang B, Hu P, Qiu H, Qian S, Chen X, Huang G
Ai Zheng
. 2004 Nov;
23(11 Suppl):1470-2.
PMID: 15566660
Background & Objective: The majority of cancer chemotherapy can lead to bone marrow depression, which often affects clinical response as chemotherapy can not be carried out with enough dosage on...
10.
Huang G, Zhao C, Han F, Zhang B, Qiu H, Xu B, et al.
Ai Zheng
. 2003 Oct;
22(10):1084-7.
PMID: 14558957
Background & Objective: Oropharyngeal mucositis is the most common acute non-hematology toxicity in nasopharyngeal carcinoma (NPC) treated with radiotherapy, especially in the concomitant chemoradiotherapy of local advanced NPC patients. This...